CVI Holdings’s Benitec Biopharma Limited BNTCW Stock Holding History

CVI Holdings’s Portfolio BNTCW Stock Details BNTCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-50,000	Closed	-$2K	–	89
2020 Q1	$2K	Hold	50,000	–	–	0.01%	33
2019 Q4	$4K	Hold	50,000	–	–	0.01%	33
2019 Q3	$1K	Hold	50,000	–	–	﹤0.01%	39
2019 Q2	$1K	Hold	50,000	–	–	﹤0.01%	61
2019 Q1	$6K	Hold	50,000	–	–	0.01%	52
2018 Q4	$6K	Hold	50,000	–	–	0.01%	33
2018 Q3	$6K	Hold	50,000	–	–	0.01%	41
2018 Q2	$6K	Hold	50,000	–	–	0.01%	47
2018 Q1	$12K	Buy	+50,000	New	+$17.7K	0.02%	40

CVI Holdings's BNTCW Position: Q2 2020 in Review

CVI Holdings sold out of Benitec Biopharma Limited (BNTCW) in Q2 2020, closing a stake of 50,000 shares — an estimated $2K sold.

CVI Holdings first reported a position in BNTCW in Q1 2018 and held it in 9 quarters. The position peaked at $12K in Q1 2018. 0 funds tracked by Wall St. Rank hold BNTCW as of Q2 2020.

CVI Holdings reported no remaining Benitec Biopharma Limited position as of Q2 2020 after selling out during the quarter.
CVI Holdings sold 50,000 Benitec Biopharma Limited shares in Q2 2020, an estimated $2K.
CVI Holdings first reported a position in Benitec Biopharma Limited in Q1 2018 and held it in 9 quarters.
CVI Holdings's Benitec Biopharma Limited position peaked at $12K in Q1 2018.
0 funds tracked by Wall St. Rank held Benitec Biopharma Limited as of Q2 2020.

Based on CVI Holdings's 13F filing for Q2 2020, filed 14 Aug 2020.